Abstract
Potent immunosuppressive therapies increased the rate of successful solid organ transplantations, but are also associated with augmented risk for infections. The pathogens can originate from the pretransplant period (endogenous reactivation), donor-derived, or newly acquired. Immunosuppression can disguise infection by mild clinical symptoms and atypical laboratory constellation. Therefore, it is important to consider early in the process a systematic diagnostic workflow including rare pathogens which are sometimes not detectable by routine methods.
| Translated title of the contribution | Infections after solid organ transplantation |
|---|---|
| Original language | German |
| Journal | Notfall und Rettungsmedizin |
| Volume | 20 |
| Issue number | 3 |
| Pages (from-to) | 199-205 |
| Number of pages | 7 |
| ISSN | 1434-6222 |
| DOIs | |
| Publication status | Published - 01.05.2017 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Infections after solid organ transplantation'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver